While it does activate GLP-1 receptors like semaglutide, it has five times stronger affinity for GIP receptors, creating a metabolic signal your body doesn't get from GLP-1 medications alone
We speculate that Phascolarctobacterium may be involved in the development of HT
Recent health data from the UAE show that approximately 30% of adults are obese, while more than 15% have been diagnosed with type 2 diabetes
For many users, this translates to smaller meals, fewer snacks and greater intention around their daily intake
If you are going to start any GLP-1 receptor agonists, please stop the DPP-4 inhibitors [7]
Semaglutide has been shown in clinical trials to be an effective treatment for weight loss, with some patients losing up to 10% of their body weight within one year of taking the medication